Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces Cerevisiae, the baker's yeast, in vitro

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 981-989

  Ghoneum, Mamdooh ^a   Hamilton, Jason ^a   Brown, Jimmy ^a   Gollapudi, Sastry ^b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 cerevisiae; Apoptosis; Caco 2; Oxidative burst; Phagocytosis; SCC 4

Indexed keywords

BAKER YEAST EXTRACT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ARTICLE; CELL KILLING; COLON ADENOCARCINOMA; COLON CARCINOMA; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME INHIBITION; EVALUATION; FLOW CYTOMETRY; HEATING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; OXIDATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; SACCHAROMYCES CEREVISIAE; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ADENOCARCINOMA; AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CACO-2 CELLS; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; HUMANS; PHAGOCYTOSIS; SACCHAROMYCES CEREVISIAE; TONGUE NEOPLASMS; U937 CELLS;

EID: 17444410828     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. American Cancer Society: Cancer facts and figures 1997. American Cancer Society Atlanta, GA 2002.
2. Lacy P, Piccirillo J, Merritt M and Zequeira M: Head and neck squamous cell carcinoma: better to be young. Otolaryngol Head Neck Surg 122: 253-258, 2000.
3. Munoz BF, Gonzalez AJ, Galera RH, Delgado MF and Galera DH: Advances in the diagnosis of ENT tumors in childhood. An Pediatr (Barc) 58: 456-463, 2003. Review.
4. Hosch SB, Stoecklein NH and Izbicki JR: Molecular markers and staging of early esophageal cancer. Langenbecks Arch Surg 388: 77-82, 2003. Review.
5. Zong YS, Zhong BL, Liang YJ, Zhang M, Lin SX, He JH et al: Advancement of studying the biological characteristics of nasopharyngeal carcinogenesis. Ai Zheng 21: 686-695, 2002. Review.
6. Boyle P and Langman JS: ABC of colorectal cancer: epidemiology. Br Med J 321: 805-808, 2000.
7. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K and Edwards BK: The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88: 2398-2424, 2000.
8. Midgley RS and Kerr DJ: Colorectal cancer. Lancet 353: 391-399, 1999.
9. Young A and Rea D: ABC of colorectal cancer: Treatment of advanced disease. Br Med J 321: 1278-1281, 2000.
10. Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi J, Zhang W et al: Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res 63: 4037-4043, 2003.
11. Motohashi N, Wakabayashi H, Kurihara T, Takada Y, Maruyama S, Sakagami H et al: Cytotoxic and multidrug resistance reversal activity of a vegetable, 'Anastasia Red', a variety of sweet pepper. Phytother Res 17: 348-352, 2003.
12. Balasenthil S, Rao KS and Nagini S: Garlic induces apoptosis during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Oral Oncol 38: 431-436, 2002.
13. Lee E and Surh Y: Induction of apoptosis in HL-60 cells by punget vanilloids, [6]-gingeroland[6]-paradol. Cancer Letters 134: 163-168, 1998.
14. Motohashi N, Shirataki Y, Kawase M, Tani S, Sakagami H, Satoh K et al: Cancer prevention and therapy with kiwifruit in Chinese folklore medicine: a study of kiwifruit extracts. J Ethnopharmacol 81: 357-64, 2002.
15. Ghoneum M and Gollapudi S: Induction of apoptosis in human breast cancer cells by Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res 24: 1455-64, 2004.
16. Ghoneum M, Grewal I, Brown J, Osborne R, Elembabi H and Gill G: Phagocytosis of Candida albicans by lymphatic tumor cells in vitro. Acta histochemica 105: 127-33, 2003.
17. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-39, 1992.
18. Martin SJ and Green DR: Apoptosis as a goal of cancer therapy. Curr Opin Oncol 6: 616-21, 1994.
19. Eastman A: Activation of programmed cell death by anticancer agents: cisplatin as a system model. Cancer Cells 2: 275-80, 1990.
20. Friesen C, Herr I, Krammer PH and Debatin KM: Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2: 574-7, 1996.
21. Marchetti P, Mortier L, Beauvillain V and Formstecher P: Are mitochondria targets of anticancer drugs responsible for apoptosis?. Ann Biol Clin (Paris) 60: 391-403, 2002.
22. Sorenson CM, Barry MA and Eastman A: Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-55, 1990.
23. Andersson A, Fagerberg J, Lewensohn R and Ehrsson H: Pharmacokinetics of cisplatin and its monohydrated complex in humans. J Pharm Sci 85: 824-7, 1996.
24. Ghoneum M, Salem F, Shum ST, Perry L and Gill G: In situ lymphophagocytosis by nonlymphoreticular neoplasms. Nat Immun Cell Growth Regul 6: 77-87, 1987.
25. Ghoneum M, Salem F, Allen H and Gill G: Phagocytosis of autologous lymphocytes by cervical preneoplastic and neoplastic cells. Natur Immunt Cell Growth Regul 7: 239-48, 1988.
26. Marin-Padilla M: Erythrophagocytosis by epithelial cells of a breast carcinoma. Cancer 39: 1085-9, 1977.
27. Vandenberghe J, Verheyen A, Lauwers S and Geboes K: Spontaneous adenocarcinoma of the ascending colon in Wistar rats: the intracytoplasmic presence of a Campylobacter-like bacterium. J Comp Pathol 95: 45-55, 1985.
28. Kiyohara T, Kumakiri M, Kobayashi H, Ohkawara A and Lao L-M: Atrophic dermatofibroma. Elastophagocytosis by the tumor cells (Report). J Cutan Pathol 27: 312-5, 2000.
29. Osano E, Kishi J and Takahashi Y: Phagocytosis of titanium particles and necrosis in TNF-alpha-resistant mouse sarcoma L929 cells. Toxicol In Vitro 17: 41-7, 2003.
30. Montcourrier P, Mangeat PH, Valembois C et al: Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cancer Science 107: 2381-91, 1994.
31. Coopman PJ, Do MT, Thompson EW and Mueller SC: Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 4: 507-15, 1998.
32. Ghoneum M and Gollapudi S: Phagocytosis of Candida albicans by human metastatic and non-metastatic breast cancer cells in vitro. Cancer Detection & Prevention 28: 17-26, 2004.
33. Rowland AC and Lawson GH: Intestinal adenomatosis in the pig: a possible relationship with a haemorrhagic enteropathy. Res Vet Sci 18: 263-8, 1975.
34. McCartney E, Lawson GH and Rowland AC: Behaviour of Campylobacter sputorum subspecies mucosalis in gnotobiotic pigs. Res Vet Sci 36: 290-7, 1984.
35. Lawson GH, Rowland AC and MacIntyre N: Demonstration of a new intracellular antigen in porcine intestinal adenomatosis and hamster proliferative ileitis. Vet Microbiol 10: 303-13, 1985.
36. Weglarczyk K, Baran J, Zembala M and Pryjma J: Caspase-8 activation precedes alterations of mitochondrial membrane potential during monocyte apoptosis induced by phagocytosis and killing of Staphylococcus aureus. Infect Immun 72: 2590-7, 2004.
37. Baran J, Weglarczyk K, Mysiak M et al: Fas (CD95)-Fas ligand interactions are responsible for monocyte apoptosis occurring as a result of phagocytosis and killing of staphylococcus aureus. Infect Immun 69: 1287-97, 2001.
38. Watson RW, Redmond HP, Wang JH, Condron C and Bouchier-Hayes D: Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 156: 3986-92, 1996.
39. Perskvist N, Long M, Stendahl O and Zheng L: Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway. J Immunol I: 6358-65, 2002.
40. Rotstein D, Parodo J, Teneja R and Marshall JC: Phagocytosis of candida albicans induces apoptosis of human neutrophils. Shock 14: 278-83, 2000.
41. Coley WB: The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases (1893). Clin Orthop Rel Res 262: 3-11, 1991.
42. Nauts HC, Swift WE and Coley BL: The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research. Cancer Res 6: 205-216, 1946.
43. Lamm DL, Thor DE, Harris SC, Reyna JA, Stogdill VD and Radwin HM: Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer. J Urol 124: 38-40, 1980.
44. Morales A, Edinger D and Bruce AW: Intracavity Bacillus Calmette Guerin in the treatment of superficial bladder tumours. J Urol 116: 180-183, 1976.
45. Thanhauser A, Bohle A, Schneider B et al: The induction of Bacillus Calmette-Guerin-activated killer cells requires the presence of monocytes and T helper type-1 cells. Cancer Immunol Immunother 40: 103-8, 1995.
46. Eisenstein TK, Bushnell B, Meissler JJ Jr, Dalal N, Schafer R and Havas HF: Immunotherapy of a plasmacytoma with attenuated Salmonella. Med Oncol 12: 103-108, 1995.
47. Gill GV and Holden A: A malignant pleural effusion infected with Salmonella enteritidis. Thorax 51: 104-105, 1996.
48. Pawelek J M, Low KB and Bermudes D: Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57: 4537-4544, 1997.
49. Sznol M, Lin SL, Bermudes D, Zheng L-M and King I: Use of preferentially-replicating bacteria for the treatment of cancer. J Clin Investig 105: 1027-1030, 2000.
50. Dang LH, Bettegowda C, Huso DL, Kinzler KW and Vogelstein B: Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci USA 98: 15155-15160, 2001.
51. Glinsky G V and Glinsky VV: Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett 101: 43-51, 1996.
52. Glinsky GV, Glinsky VV, Ivanova AB and Hueser CJ: Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett 115: 185-93, 1997.